NCT04388501View on ClinicalTrials.gov

A Study Evaluating Drug Drug Interaction Between Milvexian and Atorvastatin in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

June 7, 2021

Primary Completion Date

October 25, 2021

Study Completion Date

October 27, 2021

Conditions
Healthy
Interventions
DRUG

Milvexian

Participants will receive milvexian capsules orally qd for 5 days as per the assigned treatment sequence.

DRUG

Atorvastatin

Participants will receive atorvastatin tablets orally qd for 5 days as per the assigned treatment sequence.

Trial Locations (1)

2170

Clinical Pharmacology Unit, Merksem

All Listed Sponsors
lead

Janssen Pharmaceutica N.V., Belgium

INDUSTRY